l carnitine and graves disease L-Carnitine, Selenium & Thyroid Health Carnitine Deficiency: What You Need

6 Nature Reviews / Diabetes Obes Metab Dual GLP-1 + amylin agonismMechanistic review of combining GLP-1 receptor agonism with amylin analog therapy for appetite and satiety

[DOI] [PMC free article] [PubMed] [Google Scholar] Mukai T

doi: 10.3945/ajcn.110.008409

To identify the acetylation sites in SnCE1 and to narrow down the sites that are enzymatically regulated we performed mass spectrometry on acetylated wild type SnCE1, SIRT1-treated wild type SnCE1 and analyzed the non-acetylated mutant SnCE1 Y212A as a control (Supplementary Fig

Future studies should focus on more precisely quantifying the effects of different dietary factors on glaucoma progression, exploring the mechanisms underlying the differential responses between individuals, and conducting long-term interventional studies to develop more personalized and precise dietary guidance protocols

Bridging mechanistic discoveries with patient-centered outcomes through precision phenotyping, integrative therapies, and innovative trial design may ultimately establish metabolic modulation as a cornerstone in HF management